Tuesday, November 12, 2019

Georgia Unveils Bold ACA Waiver Plan


More than a year after the Trump administration issued controversial new guidelines for the Affordable Care Act’s Section 1332 waivers, Georgia became the first state to take CMS up on that increased flexibility by unveiling a draft waiver proposal that would make some major changes to its individual insurance market.
The state's waiver proposal has two primary phases: first is a reinsurance program to help insurers pay high-cost claims (and thus lower premiums), set to go into effect in 2021. Then there's the "Georgia Access Model," which starting in 2022 would:
  • Direct consumers to buy coverage through private broker or insurer websites, rather than HealthCare.gov;
  • Put the state in control of ACA subsidies; and
  • Allowhealth plans that don’t cover all 10 of the ACA’s essential health benefits (EHB) categories to be sold alongside qualified health plans (QHPs).
David Anderson, a research associate at the Duke-Margolis Center for Health Policy, says the basic idea is to exclude select EHB categories which would create a lower actuarial value in exchange for cheaper premiums. In his view, the population that stands to lose the most in such a scenario is people who don't qualify for subsidies but have significant medical conditions. "Their premiums are going to skyrocket because they’re still going to need all the EHBs," he says.
Anderson predicts insurers will "love the reinsurance" portion of Georgia's proposal and be able to handle the other individual market changes. "The biggest challenge will be projecting relative risk and market share between the full EHB and the limited EHB plans," he adds.
But Joel Ario, managing director of Manatt Health, points out that "health insurers are generally risk averse; this seems to have a lot of risky dimensions to it." Some unanswered questions, he says, include how the state will implement a system with alternative enrollment channels and what type of non-QHP health plans will actually be rolled out.

No comments:

Post a Comment